Lupin Launches Thiamine Hydrochloride Injection USP in the United States
By, Admin1 min read
Share
Global pharma major Lupin Limited (Lupin) today announced the launch of Thiamine Hydrochloride Injection USP, 200 mg/2 mL (100 mg/mL) Multiple-dose Vials,after Lupin
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
